Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions

Phase 2

Completed

Conditions: Coronary Artery Disease

Interventions: Device: TAXUS Express Paclitaxel-Eluting Coronary Stent System
Device: Control stent

First Posted Date: 2006-03-01

Last Posted Date: 2017-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 448

Registration Number: NCT00297804

Locations: 🇩🇪
HELIOS Clinic, Siegburg, Germany

TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent

Phase 2

Completed

Conditions: Coronary Artery Disease

Interventions: Device: percutaneous coronary intervention

First Posted Date: 2006-02-16

Last Posted Date: 2008-10-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1326

Registration Number: NCT00292474

Locations: 🇺🇸
Stephen G.Ellis, Cleveland, Ohio, United States

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis

Phase 2

Completed

Conditions: Coronary Restenosis

Interventions: Device: TAXUS Express2
Procedure: Brachytherapy (beta source)

First Posted Date: 2006-02-07

Last Posted Date: 2010-08-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 488

Registration Number: NCT00287573

Locations: 🇺🇸
Baptist Medical Center Princeton, Birmingham, Alabama, United States
🇺🇸
Scripps Green Hospital, LaJolla, California, United States
🇺🇸
Mercy General Hospital, Sacramento, California, United States

and more 39 locations

Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing

Completed

Conditions: Heart Block
Bradycardia
Sick Sinus Syndrome

First Posted Date: 2006-02-06

Last Posted Date: 2021-01-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 903

Registration Number: NCT00286858

Locations: 🇫🇷
CHRU- Hôpital Nord, Amiens, France
🇫🇷
Clinique Cardiologique Aressy, Aressy, France
🇫🇷
Clinique du Lac et d'Argonay, Argonay, France

and more 37 locations

Treatment for Migraines With an Implantable Device

Not Applicable

Completed

Conditions: Migraine

Interventions: Device: Precision

First Posted Date: 2006-02-03

Last Posted Date: 2019-07-30

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 179

Registration Number: NCT00286078

Locations: 🇺🇸
Mile High Research Center, Denver, Colorado, United States
🇺🇸
The New England Center for Headache, Stamford, Connecticut, United States
🇺🇸
Walton Rehabilitation Hospital, Augusta, Georgia, United States

and more 12 locations

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

Not Applicable

Completed

Conditions: Symptomatic Ischemic Saphenous Vein Graft Disease

Interventions: Device: Covered Stent System
Device: Bare metal stent

First Posted Date: 2006-01-30

Last Posted Date: 2009-11-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 514

Registration Number: NCT00283413

Locations: 🇺🇸
Baptist Medical Center Princeton, Birmingham, Alabama, United States
🇺🇸
University of Alabama Hospital, Birmingham, Alabama, United States
🇺🇸
Baptist Medical Center South, Montgomery, Alabama, United States

and more 46 locations

AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction

Phase 4

Completed

Conditions: Myocardial Infarction

Interventions: Device: direct stenting
Device: rheolytic thrombectomy with direct stenting

First Posted Date: 2006-01-12

Last Posted Date: 2014-10-09

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 501

Registration Number: NCT00275990

Locations: 🇮🇹
Careggi Hospital, Division of Cardiology, Florence, Italy

MODULA Modul 5 BEAT-HF

Completed

Conditions: Heart Failure

First Posted Date: 2006-01-09

Last Posted Date: 2017-02-23

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT00273091

Locations: 🇩🇪
Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9, Bad Berka, Germany

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation

Phase 2

Completed

Conditions: Primary Liver Cancer

Interventions: Device: Transarterialchemoembolisation (TACE)
Device: DC Bead with Doxorubicin

First Posted Date: 2005-12-05

Last Posted Date: 2021-07-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 212

Registration Number: NCT00261378

Locations: 🇦🇹
Medizinische Universitat Innsbruck, Innsbruck, Austria
🇦🇹
Allgemines Krankenhaus Vienna, Vienna, Austria
🇫🇷
L'Hopital Beaujon, Clichy, France

and more 14 locations

The Boston Scientific ENOVUS Trial

Phase 2

Withdrawn

Conditions: Abdominal Aortic Aneurysm

First Posted Date: 2005-10-30

Last Posted Date: 2015-08-31

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT00246038

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy